Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration

Jan P. Vandenbroucke, Erik von Elm, Douglas G. Altman et al. · PLoS Medicine · 2007 · 8.4K citations · Full text

Public Health, Public Health Practice, Epidemiologic Methods +14

Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

Kanyin Liane Ong, Lauryn K Stafford, Susan A. McLaughlin et al. · The Lancet · 2023 · 4.2K citations · Full text

Public Health, Chronic Disease Prevention, Health Sciences +16

Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial

The Diabetes Control and Complications Trial Research Group · Archives of Ophthalmology · 1998 · 497 citations

Medicine, Ophthalmology, Clinical Vision Science +16

Assessing the Risk for Gout With Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes

Michael Fralick, Sarah K. Chen, Elisabetta Patorno et al. · Annals of Internal Medicine · 2020 · 101 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Glucagon‐like peptide‐1 receptor expression in the human eye

Josephine B. Hebsgaard, Charles Pyke, Lotte Bjerre Knudsen et al. · Diabetes Obesity and Metabolism · 2018 · 77 citations · Full text

Medicine, Endocrinology, Ophthalmology +16